×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| AMBALAL SARABHAI ENTERPRISES L | NA | NA | NA | NA | 248.0 | 13.2 |
| ASARFI HOSPITAL LIMITED | NA | NA | NA | NA | 244 | 23.7 |
| BAFNA PHARMACEUTICALS LTD. | 352.2 | 33.89 | 346.24 | 1.43 | 238 | 23.7 |
Ambalal Sarabhai Enterprise Ltd.,, with Security Code 500009, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.2 | 0.4 | 1.7 | 0.8 | 0.3 | 1.0 | 1.1 | 0.0 | 1.2 | 1.7 |
| Expenses | 2.3 | 1.7 | 4.9 | 2.1 | 2.0 | 1.6 | 2.4 | 1.8 | 3.7 | 3.4 |
| Operating Profit | -1.1 | -1.3 | -3.2 | -1.3 | -1.6 | -0.7 | -1.3 | -1.8 | -2.6 | -1.7 |
| OPM % | -91.86% | -350.54% | -184.86% | -167.21% | -499.08% | -67.31% | -110.6% | 0% | -220.55% | -97.92% |
| Other Income | 2.8 | 2.6 | 1.2 | 2.0 | 1.3 | 3.4 | 1.9 | 6.4 | 10.8 | -3.2 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 1.6 | 2.0 | -2.0 | 0.6 | -0.4 | 2.7 | 0.5 | 4.5 | 3.0 | -0.4 |
| Tax % | -0.1% | -9.2% | 0% | 0% | 69.1% | 76.4% | -5.5% | -3.3% | 3.9% | 0% |
| Net Profit | 1.6 | 1.1 | -2.0 | 0.6 | -0.7 | 4.7 | 0.5 | 4.3 | 8.4 | -5.0 |
| EPS in Rs | 0.32 | 0.15 | -0.26 | 0.07 | -0.08 | 0.62 | 0.06 | 0.56 | 1.1 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35.4 | 44.4 | 36.1 | 40.0 | 43.1 | 54.3 | 40.7 | 44.7 | 46.0 | 64.8 |
| Expenses | 33.8 | 41.1 | 40.1 | 39.0 | 40.6 | 49.7 | 40.2 | 42.2 | 46.7 | 59.4 |
| Operating Profit | 1.6 | 3.3 | -4.0 | 1.0 | 2.5 | 4.7 | 0.5 | 2.5 | -0.7 | 5.4 |
| OPM % | 4.42% | 7.53% | -10.98% | 2.53% | 5.87% | 8.56% | 1.17% | 5.68% | -1.53% | 8.31% |
| Other Income | 3.1 | 4.4 | 1.4 | 2.9 | 1.4 | 4.8 | 2.3 | 1.8 | 5.6 | -5.4 |
| Interest | 0.6 | 1.0 | 1.0 | 0.9 | 1.0 | 0.9 | 1.0 | 1.2 | 1.1 | 1.0 |
| Depreciation | 0.6 | 0.9 | 1.1 | 1.1 | 1.1 | 0.3 | 1.0 | 1.0 | 1.0 | 1.0 |
| Profit before tax | 3.5 | 5.8 | -4.6 | 1.8 | 1.8 | 8.3 | 0.8 | 2.2 | 2.8 | 5.0 |
| Tax % | -11.8% | -24.8% | 7.5% | -39.1% | -39.6% | 7.8% | -41.2% | -22.9% | -25.1% | 0% |
| Net Profit | 3.0 | 5.5 | -4.9 | 1.1 | 1.2 | 9.0 | 0.3 | 2.6 | 2.2 | -0.3 |
| EPS in Rs | 0.4 | 0.72 | -0.64 | 0.15 | 0.15 | 1.18 | 0.05 | 0.34 | 0.29 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 22% |
| 3 Years: | 44% |
| TTM: | 4213% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 19% |
| 3 Years: | 7% |
| 1 Year: | -19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 6% |
| 3 Years: | -22% |
| TTM: | 338% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 19% |
| 3 Years: | 7% |
| 1 Year: | -19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|